Show Parent

October

ERJ October Podcast: new guidelines for diagnosis and treatment of pulmonary hypertension Eur Respir J 2015; 46: E58
The 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: a practical chronicle of progress Lau Edmund M.T., Tamura Yuichi, McGoon Michael D., Sitbon Olivier Eur Respir J 2015; 46: 879-882
The 2015 guidelines for idiopathic pulmonary fibrosis: an important chapter in the evolution of the management of patients with IPF Wilson Kevin C., Raghu Ganesh Eur Respir J 2015; 46: 883-886
Classification of antituberculosis drugs: a new proposal based on the most recent evidence Caminero Jose A., Scardigli Anna Eur Respir J 2015; 46: 887-893
Multitasking basal cells: combining stem cell and innate immune duties Shaykhiev Renat Eur Respir J 2015; 46: 894-897
The double-edged sword of neutrophilic inflammation in bronchiectasis Martínez-García Miguel Ángel, Sánchez Concepción Prados, Moreno Rosa María Girón Eur Respir J 2015; 46: 898-900
Should COPD stand for “comorbidity-related obstructive pulmonary disease”? Sin Don D. Eur Respir J 2015; 46: 901-902
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT) Galiè Nazzareno, Humbert Marc, Vachiery Jean-Luc, Gibbs Simon, Lang Irene, Torbicki Adam, Simonneau Gérald, Peacock Andrew, Vonk Noordegraaf Anton, Beghetti Maurice, Ghofrani Ardeschir, Gomez Sanchez Miguel Angel, Hansmann Georg, Klepetko Walter, Lancellotti Patrizio, Matucci Marco, McDonagh Theresa, Pierard Luc A., Trindade Pedro T., Zompatori Maurizio, Hoeper Marius Eur Respir J 2015; 46: 903-975
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features Fischer Aryeh, Antoniou Katerina M., Brown Kevin K., Cadranel Jacques, Corte Tamera J., du Bois Roland M., Lee Joyce S., Leslie Kevin O., Lynch David A., Matteson Eric L., Mosca Marta, Noth Imre, Richeldi Luca, Strek Mary E., Swigris Jeffrey J., Wells Athol U., West Sterling G., Collard Harold R., Cottin Vincent Eur Respir J 2015; 46: 976-987
The PROactive instruments to measure physical activity in patients with chronic obstructive pulmonary disease Gimeno-Santos Elena, Raste Yogini, Demeyer Heleen, Louvaris Zafeiris, de Jong Corina, Rabinovich Roberto A., Hopkinson Nicholas S., Polkey Michael I., Vogiatzis Ioannis, Tabberer Maggie, Dobbels Fabienne, Ivanoff Nathalie, de Boer Willem I., van der Molen Thys, Kulich Karoly, Serra Ignasi, Basagaña Xavier, Troosters Thierry, Puhan Milo A., Karlsson Niklas, Garcia-Aymerich Judith Eur Respir J 2015; 46: 988-1000
Molecular and clinical diseasome of comorbidities in exacerbated COPD patients Faner Rosa, Gutiérrez-Sacristán Alba, Castro-Acosta Ady, Grosdidier Solène, Gan Wenqi, Sánchez-Mayor Milagros, Lopez-Campos Jose Luis, Pozo-Rodriguez Francisco, Sanz Ferran, Mannino David, Furlong Laura I., Agusti Alvar Eur Respir J 2015; 46: 1001-1010
Gender differences in adult-onset asthma: results from the Swiss SAPALDIA cohort study Hansen Sofie, Probst-Hensch Nicole, Keidel Dirk, Dratva Julia, Bettschart Robert, Pons Marco, Burdet Luc, Bridevaux Pierre-Olivier, Schikowski Tamara, Schindler Christian, Rochat Thierry, Zemp Elisabeth Eur Respir J 2015; 46: 1011-1020
A randomised, placebo-controlled study of the CXCR2 antagonist AZD5069 in bronchiectasis De Soyza Anthony, Pavord Ian, Elborn J. Stuart, Smith David, Wray Heather, Puu Margareta, Larsson Bengt, Stockley Robert Eur Respir J 2015; 46: 1021-1032
Short-chain fatty acids affect cystic fibrosis airway inflammation and bacterial growth Ghorbani Peyman, Santhakumar Prisila, Hu Qingda, Djiadeu Pascal, Wolever Thomas M.S., Palaniyar Nades, Grasemann Hartmut Eur Respir J 2015; 46: 1033-1045
Pseudomonas aeruginosa quorum sensing molecules correlate with clinical status in cystic fibrosis Barr Helen L., Halliday Nigel, Cámara Miguel, Barrett David A., Williams Paul, Forrester Douglas L., Simms Rebecca, Smyth Alan R., Honeybourne David, Whitehouse Joanna L., Nash Edward F., Dewar Jane, Clayton Andrew, Knox Alan J., Fogarty Andrew W. Eur Respir J 2015; 46: 1046-1054
Lung clearance index in cystic fibrosis subjects treated for pulmonary exacerbations Sonneveld Nicole, Stanojevic Sanja, Amin Reshma, Aurora Paul, Davies Jane, Elborn J. Stuart, Horsley Alex, Latzin Philipp, O'Neill Katherine, Robinson Paul, Scrase Emma, Selvadurai Hiran, Subbarao Padmaja, Welsh Liam, Yammine Sophie, Ratjen Felix Eur Respir J 2015; 46: 1055-1064
Biomarkers of oxidative stress following continuous positive airway pressure withdrawal: data from two randomised trials Stradling John R., Schwarz Esther I., Schlatzer Christian, Manuel Ari R., Lee Regent, Antoniades Charalambos, Kohler Malcolm Eur Respir J 2015; 46: 1065-1071
Human intermittent hypoxia-induced respiratory plasticity is not caused by inflammation Beaudin Andrew E., Waltz Xavier, Pun Matiram, Wynne-Edwards Katherine E., Ahmed Sofia B., Anderson Todd J., Hanly Patrick J., Poulin Marc J. Eur Respir J 2015; 46: 1072-1083
Chymase: a multifunctional player in pulmonary hypertension associated with lung fibrosis Kosanovic Djuro, Luitel Himal, Dahal Bhola Kumar, Cornitescu Teodora, Janssen Wiebke, Danser A.H. Jan, Garrelds Ingrid M., De Mey Jo G.R., Fazzi Gregorio, Schiffers Paul, Iglarz Marc, Fischli Walter, Ghofrani Hossein Ardeschir, Weissmann Norbert, Grimminger Friedrich, Seeger Werner, Reiss Irwin, Schermuly Ralph Theo Eur Respir J 2015; 46: 1084-1094
Biomarkers for risk of developing active tuberculosis in contacts of TB patients: a prospective cohort study Rakotosamimanana Niaina, Richard Vincent, Raharimanga Vaomalala, Gicquel Brigitte, Doherty T. Mark, Zumla Alimuddin, Rasolofo Razanamparany Voahangy Eur Respir J 2015; 46: 1095-1103
Tuberculosis associates with both airflow obstruction and low lung function: BOLD results Amaral André F.S., Coton Sonia, Kato Bernet, Tan Wan C., Studnicka Michael, Janson Christer, Gislason Thorarinn, Mannino David, Bateman Eric D., Buist Sonia, Burney Peter G.J. Eur Respir J 2015; 46: 1104-1112
Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review Raghu Ganesh, Amatto Valeria C., Behr Jürgen, Stowasser Susanne Eur Respir J 2015; 46: 1113-1130
Time trends in surgery for lung cancer in France from 2005 to 2012: a nationwide study Morgant Marie-Catherine, Pagès Pierre-Benoit, Orsini Bastien, Falcoz Pierre-Emmanuel, Thomas Pascal-Alexandre, Barthes Françoise Le Pimpec, Dahan Marcel, Bernard Alain Eur Respir J 2015; 46: 1131-1139
Simulator training for endobronchial ultrasound: a randomised controlled trial Konge Lars, Clementsen Paul Frost, Ringsted Charlotte, Minddal Valentina, Larsen Klaus Richter, Annema Jouke T. Eur Respir J 2015; 46: 1140-1149
Preclinical validation and imaging of Wnt-induced repair in human 3D lung tissue cultures Uhl Franziska E., Vierkotten Sarah, Wagner Darcy E., Burgstaller Gerald, Costa Rita, Koch Ina, Lindner Michael, Meiners Silke, Eickelberg Oliver, Königshoff Melanie Eur Respir J 2015; 46: 1150-1166
Potassium channels in pulmonary arterial hypertension Boucherat Olivier, Chabot Sophie, Antigny Fabrice, Perros Frédéric, Provencher Steeve, Bonnet Sébastien Eur Respir J 2015; 46: 1167-1177
Pulmonary vascular resistance and compliance relationship in pulmonary hypertension Chemla Denis, Lau Edmund M.T., Papelier Yves, Attal Pierre, Hervé Philippe Eur Respir J 2015; 46: 1178-1189
End-of-life care in oxygen-dependent COPD and cancer: a national population-based study Ahmadi Zainab, Lundström Staffan, Janson Christer, Strang Peter, Emtner Margareta, Currow David C., Ekström Magnus Eur Respir J 2015; 46: 1190-1193
Effects of ageing and smoking on pulmonary computed tomography scans using parametric response mapping Boudewijn Ilse M., Postma Dirkje S., Telenga Eef D., ten Hacken Nick H.T., Timens Wim, Oudkerk Matthijs, Ross Brian D., Galbán Craig J., van den Berge Maarten Eur Respir J 2015; 46: 1193-1196
Accuracy of chest high-resolution computed tomography in diagnosing diffuse cystic lung diseases Gupta Nishant, Meraj Riffat, Tanase Daniel, James Laura E., Seyama Kuniaki, Lynch David A., Akira Masanori, Meyer Cristopher A., Ruoss Stephen J., Burger Charles D., Young Lisa R., Almoosa Khalid F., Veeraraghavan Srihari, Barker Alan F., Lee Augustine S., Dilling Daniel F., Inoue Yoshikazu, Cudzilo Corey J., Zafar Muhammad A., McCormack Francis X. Eur Respir J 2015; 46: 1196-1199
Blood stem cell transplantation to treat cystic lung light chain deposition disease Borgne Aurélie Le, Prévot Grégoire, Rouquette Isabelle, Huynh Anne, Têtu Laurent, Projetti Fabrice, Carreiro Miguel, Borie Raphaël, Jaccard Arnaud, Recher Christian, Didier Alain Eur Respir J 2015; 46: 1199-1202
Reversal of central sleep apnoea with change from methadone to buprenorphine-naloxone: a case report Wang David, Lintzeris Nicholas, Leung Stefanie, Haber Paul S., Yee Brendon J., Grunstein Ronald R. Eur Respir J 2015; 46: 1202-1205
Linezolid tolerability in multidrug-resistant tuberculosis: a retrospective study Bolhuis Mathieu S., Tiberi Simon, Sotgiu Giovanni, De Lorenzo Saverio, Kosterink Jos G.W., van der Werf Tjip S., Migliori Giovanni Battista, Alffenaar Jan-Willem C. Eur Respir J 2015; 46: 1205-1207
Airway bacteria and respiratory symptoms are common in ambulatory HIV-positive UK adults Nimmo Camus, Capocci Santino, Honeyborne Isobella, Brown James, Sewell Janey, Thurston Sarah, Johnson Margaret, McHugh Timothy D., Lipman Marc Eur Respir J 2015; 46: 1208-1211
Nasal decongestant exposure in patients with pulmonary arterial hypertension: a pilot study Perrin Swanny, Montani David, O'Connell Caroline, Günther Sven, Girerd Barbara, Savale Laurent, Guignabert Christophe, Sitbon Olivier, Simonneau Gerald, Humbert Marc, Chaumais Marie-Camille Eur Respir J 2015; 46: 1211-1214
Pulmonary tumour thrombotic microangiopathy: unclassifiable pulmonary hypertension? Kumar Neelam, Price Laura C., Montero M. Angeles, Dimopoulos Konstantinos, Wells Athol U., Wort S. John Eur Respir J 2015; 46: 1214-1217
Switching to nintedanib after discontinuation of pirfenidone due to adverse events in IPF Milger Katrin, Kneidinger Nikolaus, Neurohr Claus, Reichenberger Frank, Behr Jürgen Eur Respir J 2015; 46: 1217-1221
Pulse oximetry oxygen saturation during the 6-min walk test: a limit for stopping the test without resuming it Piaggi Giancarlo, Gambazza Simone, Guarise Riccardo, Piran Manuela Eur Respir J 2015; 46: 1222-1223
Guidance for the regulatory status of allergen extracts in clinical trials Diamant Zuzana, van Maaren Maurits, van Wijk Roy Gerth, Brouwers Jacobus R.B.J., Pieterse Herman Eur Respir J 2015; 46: 1223-1225
“Dead space: the physiology of wasted ventilation.” H. Thomas Robertson. Eur Respir J 2015; 45: 1704–1716. Eur Respir J 2015; 46: 1226